zacks.com / Page 4

Despite subdued market performance, a decent rise in AUM balance, driven by inflows, is expected to have supported AMP's Q1 earnings.

FE first-quarter 2025 results are expected to benefit from improved service reliability. Yet, severe storms might have offset some positives.

The Empire Wind project, set to power 500,000 homes, is now on hold as EQNR complies with a federal halt order and assesses potential project risks and liabilities.

LMT might disappoint with its first-quarter results, considering its dismal year-to-date share price performance and negative Earnings ESP.

FTI is expected to report higher revenues than the year-ago period's level. However, the company is likely to have faced increased costs and expenses.

Devoid of marketed drugs, investors will focus on VKTX's pipeline updates when it reports first-quarter earnings.

AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, are expected to have driven the company's top line.

MainStreet Bank (MNSB) delivered earnings and revenue surprises of 19.05% and 1.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

TYL's Q1 results are likely to reflect benefits from robust demand for SaaS solutions as the public sector shifts from on-premise to cloud-based systems.

Universal Technical (UTI) could produce exceptional returns because of its solid growth attributes.